ArticleJournal of neuro-oncology2016
Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.
Jacob J Mandel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papertrialcites it